We therefore hypothesized that PAK1 inhibition in combination with microtubule stabilizing chemotherapeutic agent taxanes, such as docetaxel (Taxotere, DTX), could synergistically alter microtubule dynamics in breast cancer cells leading to greater cell death [25]. This evidence concerns the gene PAK1 and breast carcinoma.